Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker (Q32118936)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

0 references

Chris J.L.M. Meijer

6

object named as

Meijer CJ

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

author name string

ten Berge RL

1

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Oudejans JJ

2

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Dukers DF

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Meijer JW

4

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Ossenkoppele GJ

5

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

458-464

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypic analysis of large cell lymphomas which express the Ki-1 antigen

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Rare occurrence of classical Hodgkin's disease as a T cell lymphoma

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Anaplastic large cell lymphoma (CD30 /Ki-1 ): results of a prospective clinico-pathological study of 69 cases.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

The expression of TIA-1 cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30 anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

BCL-2 FAMILY: Regulators of Cell Death

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Human and viral interleukin‐10 in Hodgkin's disease, and its influence on CD4 and CD8 T lymphocytes

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402045

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402045

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32118936&oldid=2175456955"